Alvotech enters into commercialization agreement with
Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area,
Globe Newswire6-02-2023, 16:08
Dialing Up Nights Out: Heineken® & Bodega Launch the No-Frills ‘Boring Phone’ 17-04-2024, 15:02